Retransplantation for late liver graft failure: predictors of mortality.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 10719016)

Published in Liver Transpl on March 01, 2000


M Facciuto1, D Heidt, J Guarrera, C A Bodian, C M Miller, S Emre, S R Guy, T M Fishbein, M E Schwartz, P A Sheiner

Author Affiliations

1: Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY 10029, USA.

Articles by these authors

Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14

Prevalence and natural history of cryptorchidism. Pediatrics (1993) 2.79

Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65

Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg (1999) 2.51

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18

Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14

Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07

Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96

Neurologic outcome after ascending aorta-aortic arch operations: effect of brain protection technique in high-risk patients. J Thorac Cardiovasc Surg (2001) 1.93

Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry (2010) 1.83

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67

Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg (1990) 1.62

Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61

One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61

Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol (2000) 1.59

Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55

N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52

Interaction-induced shift of the cyclotron resonance of graphene using infrared spectroscopy. Phys Rev Lett (2010) 1.51

Brucella infection with pancytopenia after pediatric liver transplantation. Transpl Infect Dis (2012) 1.45

Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr (2001) 1.43

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42

Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41

Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40

Retrograde cerebral perfusion during thoracic aortic surgery and late neuropsychological dysfunction. Eur J Cardiothorac Surg (2001) 1.40

Arterial blood pressure and heart rate discrepancies between handwritten and computerized anesthesia records. Anesth Analg (2000) 1.40

Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol (2009) 1.34

Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34

A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32

Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30

ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28

Etiology of chronic renal failure in Turkish children. Pediatr Nephrol (1995) 1.27

Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25

Prospective study of the natural history of thoracic aortic aneurysms. Ann Thorac Surg (1997) 1.23

Totally laparoscopic full left hepatectomy for living donor liver transplantation in adolescents and adults. Am J Transplant (2013) 1.20

Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg (2001) 1.20

Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol (2000) 1.19

Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17

Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16

Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis (1996) 1.16

The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol (2014) 1.13

Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant (2007) 1.13

Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12

Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11

Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11

The relationship of cognitive, personality, and academic measures to anesthesiology resident clinical performance. Anesth Analg (1999) 1.10

Safe use of hepatic allografts from donors older than 70 years. Transplantation (1996) 1.09

Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08

A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics (2000) 1.07

Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr (2000) 1.07